ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Consumer Non-Durables

Dabur India Ltd.

  • 357.00 INR
  • +2.80
  • +0.79%
  • India
    Apr 20, 2018
  • Ticker
    BOM(500096)
  • Prev. close
    354.20
  • Market cap (INR)
    623,930.56M
  • Market cap (USD)
    9,448.30M
  • Shares
    1,761.52M

Company Background

The world's largest ayurvedic and natural health care company, Dabur India is building its presence in the global consumer goods business. The company was founded by S.K. Burman in 1884. It started as an ayurvedic medicine business in a small pharmacy in eastern Kolkata. In the local language, Burman was commonly called Daktar Burman (Doctor Burman); the company's name combines the syllables "da" and "bur."

Today, Dabur India's products are available in more than 60 countries and span categories including hair care, skin care, health care and food. About 68% of its shares are held by the Burman family, which lets employees run the show. The company has subsidiaries in countries such as the U.K, Nepal, Egypt and Turkey; international sales make up 30% of the consolidated total.

Sunil Duggal, an electrical and electronics engineering graduate, has served as CEO since June 2002. Prior to joining Dabur India's family products division as general manager of sales and marketing in 1995, he worked for businesses such as Wimco and Pepsi Foods.

Dabur's second-biggest brand, Vatika, focuses on hair care. Launched when Duggal was in the family products division, the brand became a major growth engine for the company.

Business Summary

Dabur India Ltd. is consumer goods company, which engages in the provision of hair care, oral care, skin care, health care, home care, and foods. It operates through the following business units: Consumer Care Business, Foods Business, Retail Business and Others. The Consumer Care Business unit involves in providing health care products, such as health supplements, and digestives ad ethical. The Foods Business unit offers packaged fruit juices and culinary products. The Retail Business segment includes retail stores. The Others segment include guar gum, pharma and others. The company was founded by Saket K. Burma in 1884 and is headquartered in Ghaziabad, India.

Financial Highlights

Mar 2017 INRUSD
Revenue76,103M1,134.89M
Gross Profit27,689.60M412.92M
Operating income13,939.50M207.87M
Income before tax16,104M240.15M
Net income12,769.40M190.42M
EBITDA15,356.20M229.00M
Diluted EPS7.210.10
Dividends Per Share2.250.03
Total Assets87,341.50M1,345.06M
Total liabilities38,619.90M594.74M
Total equity48,473.90M746.49M
Operating cash flow13,817.80M206.06M
Currency in INRCurrency in USD

Historical Data

 Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue 61,177.50M 70,370.70M 77,747.60M 77,774.20M 76,103M
Gross Profit 23,554.30M 27,643.50M 30,634.90M 29,320.10M 27,689.60M
Operating income 9,014.70M 10,432.80M 11,937.60M 13,990.20M 13,939.50M
Income before tax 9,484.20M 11,355.30M 13,193.60M 15,538M 16,104M
Net income 7,634.20M 9,139.20M 10,658.30M 12,511.50M 12,769.40M
EBITDA 10,138.70M 11,407.70M 13,087.40M 15,308.70M 15,356.20M
Diluted EPS 4.35 5.21 6.03 7.07 7.21
Dividends Per Share 1.50 1.75 2 2.25 2.25
Total Assets 52,537.80M 59,702.20M 68,720.40M 78,227.20M 87,341.50M
Total liabilities 31,173.40M 32,983.50M 34,997.40M 36,304M 38,619.90M
Total equity 21,243.80M 26,559.60M 33,541.40M 41,706.10M 48,473.90M
Operating cash flow 8,895.70M 11,620.50M 11,174.40M 12,950.80M 13,817.80M
 Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Revenue 1,124.06M 1,164.41M 1,271.56M 1,187.92M 1,134.89M
Gross Profit 432.78M 457.41M 501.03M 447.83M 412.92M
Operating income 165.63M 172.63M 195.23M 213.68M 207.87M
Income before tax 174.26M 187.89M 215.78M 237.32M 240.15M
Net income 140.26M 151.22M 174.31M 191.10M 190.42M
EBITDA 186.28M 188.76M 214.04M 233.82M 229.00M
Diluted EPS 0.07 0.08 0.09 0.10 0.10
Dividends Per Share 0.02 0.02 0.03 0.03 0.03
Total Assets 966.65M 999.66M 1,098.09M 1,181.27M 1,345.06M
Total liabilities 573.56M 552.27M 559.23M 548.21M 594.74M
Total equity 390.87M 444.71M 535.96M 629.78M 746.49M
Operating cash flow 163.44M 192.28M 182.75M 197.81M 206.06M

Valuation Measures

Mar 2017
PER38.22
ROA15.42%
ROE28.31%
Operating margin18.31%
Profit margin16.77%

Key executives

  • Chief Executive Officer & Executive Director: Sunil Duggal
  • Chief Financial Officer: Lalit Malik
  • Secretary, VP-Finance & Compliance Officer: Ashok Kumar Jain
  • Executive Director & Director-Corporate Affairs: Pritam Das Narang
  • Executive Vice President-Sales: Adarsh Sharma

Shareholders

  • BURMAN ANAND CHAND (16.8%)
  • BURMAN SIDHARTH (12.3%)
  • BURMAN VIVEK CHAND (12.3%)
  • BURMAN ASHA (11.4%)
  • BURMAN PRADIP (8.9%)
  • Life Insurance Corp. of India (4.2%)
  • BURMAN MONICA (3.0%)
  • Matthews International Capital Management LLC (1.9%)
  • First State Investment Management (UK) Ltd. (1.7%)
  • BURMAN MOHIT VIVEK (1.5%)

Contact Details

  • Website:http://www.dabur.com
  • Address: Dabur Corporate Office, Kaushambi, Ghaziabad, 201010, India
  • Phone: +91.120.3982000

Related Companies

  • Dabur Lanka Pvt Ltd.
  • Naturelle LLC
  • Dabur Egypt Trading Ltd.
  • Dabur Pharmaceuticals Ltd.
  • Dabur Egypt Ltd.
  • Dabur Oncology Plc
  • Dabur International Ltd. (United Kingdom)
  • Dermoviva Skin Essentials, Inc.
  • Dabur Foods Ltd.
  • Dabur International Ltd.
  • Dabur Finance Ltd.
  • Fem Care Pharma Ltd.
  • Besta Cosmetics Ltd.
  • Balsara Hygiene Products Ltd.
  • Balsara Home Products, Ltd.
  • Shri Dhanwantry Educational Society
  • Excelsia Foods Ltd
  • Redrock Ltd

Competitors

  • Bajaj Corp Limited
  • Agro Tech Foods Limited
  • Hemas Holdings Ltd.
Last Updated on 20 Apr, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

3 months for $9

Get unlimited access
NAR site on phone, device, tablet

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media